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Introduction
Caveolae are a characteristic feature of most mammalian cell 
types (Parton and Simons, 2007). The major membrane pro-
tein components of caveolae, caveolins, are integral membrane 
proteins that bind cholesterol and form high molecular weight 
oligomers (Monier et al., 1996). Caveolin-1 (Cav1), the major 
nonmuscle isoform of the caveolin family, is essential for 
caveola formation (Fra et al., 1995; Drab et al., 2001). Loss of 
Cav1 in mice and human patients causes severe lipid dysregu-
lation, including perturbation of lipid storage (Razani et al., 
2002; Fernandez et al., 2006; Le Lay et al., 2006), disruption 
of lipolysis (Cohen et al., 2004), insulin resistance (Capozza 
et al., 2005), and a severe lipodystrophy (Garg and Agarwal, 
2008; Kim et al., 2008). Caveolae have also been implicated 
in the regulation of cell proliferation, mechanosensation, and 
endocytosis of specific cargoes (Tagawa et al., 2005; Yao et al., 
2005; Cheng et al., 2006; Parton and Simons, 2007). Caveo-
lins have also been strongly linked to disease states including 
breast and prostate cancer (Lee et al., 1998; Tahir et al., 2008) 
and, in the case of the muscle-specific Caveolin-3 (Cav3), 
muscle diseases known as caveolinopathies (for a review see 
Woodman et al., 2004).
Until recently, studies of caveolae have invariably focused 
on caveolins in the absence of information on other bona fide 
caveolar machinery proteins. However, although caveolins are 
essential for biogenesis of caveolae, recent studies have high-
lighted additional levels of regulation of caveola formation 
and potentially function. These studies have shown a role for 
 Polymerase I and transcript release factor (PTRF)/Cavin is a cytoplasmic protein whose expression is obligatory for caveola formation. Using biochemis-
try and fluorescence resonance energy transfer–based 
approaches, we now show that a family of related 
proteins, PTRF/Cavin-1, serum deprivation response 
(SDR)/Cavin-2, SDR-related gene product that binds to 
C kinase (SRBC)/Cavin-3, and muscle-restricted coiled-
coil protein (MURC)/Cavin-4, forms a multiprotein com-
plex that associates with caveolae. This complex can 
constitutively assemble in the cytosol and associate with 
caveolin at plasma membrane caveolae. Cavin-1, but 
not other cavins, can induce caveola formation in a 
heterologous system and is required for the recruitment 
of the cavin complex to caveolae. The tissue-restricted ex-
pression of cavins suggests that caveolae may perform 
tissue-specific functions regulated by the composition 
of the cavin complex. Cavin-4 is expressed predominantly 
in muscle, and its distribution is perturbed in human 
muscle disease associated with Caveolin-3 dysfunction, 
identifying Cavin-4 as a novel muscle disease candidate 
caveolar protein.
MURC/Cavin-4 and cavin family members form 
tissue-specific caveolar complexes
Michele Bastiani,1 Libin Liu,4 Michelle M. Hill,1 Mark P. Jedrychowski,4 Susan J. Nixon,1 Harriet P. Lo,1  
Daniel Abankwa,1 Robert Luetterforst,1 Manuel Fernandez-Rojo,1 Michael R. Breen,4 Steven P. Gygi,5  
Jorgen Vinten,6 Piers J. Walser,1 Kathryn N. North,3 John F. Hancock,1 Paul F. Pilch,4 and Robert G. Parton1,2
1Institute for Molecular Bioscience and 2Center for Microscopy and Microanalysis, The University of Queensland, Brisbane, Queensland 4072, Australia
3Institute for Neuromuscular Research, The Children’s Hospital at Westmead, Sydney, New South Wales 2145, Australia
4Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118
5Department of Cell Biology, Harvard Medical School, Boston, MA 02115
6Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen N 2200, Denmark
© 2009 Bastiani et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publica-
tion date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 o
n
 O
ctober 15, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published June 22, 2009
http://jcb.rupress.org/content/suppl/2009/06/22/jcb.200903053.DC1.html 
Supplemental Material can be found at:
JCB • VOLUME 185 • NUMBER 7 • 2009 1260
Results
Identification of PTRF/Cavin-related 
proteins; MURC/Cavin-4 is a muscle-
enriched PTRF family member
Through sequence homology searches, we identified a putative 
PTRF/SDR family member, which we term Cavin-4 (Fig. 1 a). 
Cavin-4 has been predicted by the Functional Annotation of the 
Mammalian cDNA Consortium, the Institute of Physical and 
Chemical Research Genome Exploration Research Group, and 
the Genome Science Group (Genome Network Project Core 
Group; cDNA clone 2310039E09; Carninci et al., 2005). 
Cavin-4 protein has subsequently been annotated by Swissprot 
(accession no. A2AMM0) and recently reported as MURC, 
a cardiac and skeletal muscle–specific protein (Ogata et al., 
2008; Tagawa et al., 2008).
The MURC/Cavin-4 gene localizes to human chromo-
some 9 (contig 102,380,247–102,388,554) and mouse chromo-
some 4 (contig 48,676,386–48,686,364), and in both species, 
the gene comprises two exons; this genomic organization seems 
to be conserved in all species identified. As shown in Fig. 1 
(b and c), the mouse Cavin-4 sequence encodes a protein of 362 
amino acids, which shares structural PEST (proline, glutamic 
acid, serine, and threonine-rich) domains with other cavins. 
Interestingly, all the family members are predicted to have regions 
of intrinsic disorder, which are coincident with the predicted 
PEST domains (disorder predictions made at http://bioinf.cs 
.ucl.ac.uk/disopred/index.html). In addition to the PEST do-
mains, PTRF/Cavin-1, SDR/Cavin-2, and SRBC/Cavin-3 are also 
predicted to have leucine-rich regions (putative leucine zipper), 
and Cavin-1 contains polybasic regions (possible nuclear local-
ization signals).
Orthologues of Cavin-4 were identified in mammals, fish, 
and frogs but not Caenorhabditis elegans. Murine Cavin-4 
shows 29% homology and 49% similarity to Cavin-1, 24% homol-
ogy and 42% similarity to Cavin-2, and 20% homology and 39% 
similarity to Cavin-3 (Fig. 1 e). Evolutionary analysis (Fig. 1 d) 
demonstrated distinct clades for the family members. The se-
quence homology between all the family members is higher in 
the N-terminal region (Fig. 1 c; Gustincich et al., 1999; Xu 
et al., 2001), and based on this, we propose that this family of 
proteins shares two homology regions (Fig. 1c) with 61–77% 
sequence similarity in region I and 78–87% in region II among 
the cavin family members.
The tissue distribution of Cavin-1 closely parallels that of 
Cav1 (Hill et al., 2008; Liu et al., 2008). To examine the tissue 
distribution of the other family members, we performed immuno-
blotting using affinity-purified rabbit antibodies to each cavin. 
As shown in Fig. 2 a, the tissue distribution of Cavin-2 and -3 
also correlates with Cav1 expression. For Cavin-4, in agree-
ment with other data (Cancer Genome Anatomy Project virtual 
northern expression pattern for cluster UniGene accession no. 
Hs.99004; Tagawa et al., 2008), we detected a high expression 
level in skeletal and cardiac muscles (Fig. 2 a). We also examined 
the expression of Cavin-2 to -4 in tissues from cavin-1/ mice 
(Liu et al., 2008). As shown in Fig. 2 a, the genetic loss of Cavin-1 
results in a marked loss of Cav1-3 proteins in all tissues (80–90%; 
accessory proteins, such as polymerase I and transcript release 
factor (PTRF)/Cavin (Hill et al., 2008; Liu and Pilch, 2008; Liu 
et al., 2008), and kinases, including ARAF1 (Pelkmans and 
Zerial, 2005), which regulate caveola formation. This has 
started to change the perception of caveolae as a stable domain 
(Pelkmans et al., 2004).
PTRF/Cavin was originally described as a protein able 
to dissociate transcription complexes in vitro (Mason et al., 
1997; Jansa et al., 1998, 2001) and was more recently shown 
to localize to caveolae (Vinten et al., 2001, 2005; Voldstedlund 
et al., 2001, 2003). PTRF/Cavin is enriched in caveolar frac-
tions (Aboulaich et al., 2004), and monoclonal antibodies to 
PTRF/Cavin specifically labeled morphological caveolae in 
adipocytes (Vinten et al., 2001, 2005). PTRF/Cavin was sub-
sequently shown to be essential for caveola formation in 
mammalian cells (Hill et al., 2008; Liu and Pilch, 2008; Liu 
et al., 2008), zebrafish (Hill et al., 2008), and mice (Liu et al., 
2008). PTRF/Cavin shares sequence homology with a family 
of proteins classified as PTRF/SDR homology proteins in 
Swissprot (http://www.expasy.org). These include serum de-
privation response (SDR) gene product (also called SDPR; 
Gustincich and Schneider, 1993) and SDR-related gene prod-
uct that binds to C kinase (SRBC; Izumi et al., 1997). As well 
as showing significant sequence homology (Xu et al., 2001), 
all three proteins have been suggested to bind to phosphatidyl-
serine (PS; Burgener et al., 1990; Izumi et al., 1997; 
Gustincich et al., 1999; Hill et al., 2008). In addition, several 
studies have linked SDR and SRBC to protein kinase C (Izumi 
et al., 1997; Mineo et al., 1998) and to caveolae, including 
a proteomic study of adipocyte caveolin-enriched fractions 
(Aboulaich et al., 2004), recruitment of SDR to detergent-
 resistant floating fractions by Cav1 (Hill et al., 2008), and 
immunolocalization of SDR to caveolae (Mineo et al., 1998). 
By analogy to PTRF/Cavin, these studies raise the possibil-
ity that these related proteins regulate some aspect of caveo-
lar function.
We have now extensively characterized the members 
of the mammalian PTRF/SDR family of proteins, termed 
Cavins. Using several complementary approaches, we show 
that these proteins are coexpressed and coassociate in mam-
malian cells to form an oligomeric assembly that we term the 
Cavin complex. This complex is present in the cytosol, but in 
cells expressing caveolins, the cavin complex is associated 
with caveolae. Functional studies in a heterologous cell sys-
tem show an essential role for PTRF/Cavin-1 but not the 
other identified family members in caveola formation and 
recruitment of the cavin complex to the plasma membrane 
(Hill et al., 2008; this study). The tissue-specific expression 
of cavins suggests that each member regulates tissue-specific 
caveolae functions. We also report that a fourth member of 
the family, previously proposed to be a purely cytosolic pro-
tein (Ogata et al., 2008; Tagawa et al., 2008), is a muscle-
specific component of the cavin complex associated with the 
sarcolemmal caveolae of muscle cells. Moreover, we demon-
strate that this protein, muscle-restricted coiled-coil protein 
(MURC)/Cavin-4, is a new candidate protein for caveolin- 
associated muscle disease.
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Figure 1. The PTRF/Cavin family member proteins. (a) Summary of the names used in this paper. (b) Domain structure of cavin proteins in mouse. 
Putative PEST domains (green), leucine-rich regions (LR; orange), and nuclear localization sequences (NLS; yellow) are shown with amino acid num-
bers indicated. (c) Amino acid alignment of murine cavin proteins. Dark gray denotes identity, whereas light gray denotes similarity. Proposed cavin 
homology regions (HR) are marked with lines. Blue indicates identical amino acids, and red indicates conserved amino acids in evolution across all 
family members. Green, orange, and yellow are as indicated in b. (d) Midpoint-rooted tree showing several species containing cavin family members. 
Numbers represent the percentage of 1,000 bootstrap trials that supports the branch (numbers <70% are not depicted). (e) Percentage identity/similarity 
of murine cavin proteins.
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experiments in 3T3-L1 adipocytes showed that the loss of Cavin-1 
caused a marked reduction in Cavin-3 protein. In contrast, knock-
down of Cavin-2 in adipocytes resulted in a more modest reduc-
tion of Cavin-1 with relatively little effect on Cavin-3 (Fig. 2 b). 
We have not yet been able to achieve a significant knockdown 
of Cavin-3 in adipocytes, and at a 40–50% short hairpin RNA 
(shRNA)–mediated reduction in this protein, there is no apparent 
effect on the other caveolae proteins (unpublished data).
The cavin family proteins localize to 
caveolae and are dependent on Cav1 for 
membrane association
SDR/Cavin-2 and SRBC/Cavin-3 have been suggested to asso-
ciate with caveolae (Mineo et al., 1996; Izumi et al., 1997; 
Gustincich et al., 1999). In addition, MURC/Cavin-4 has been 
proposed to interact with Cavin-2 (Ogata et al., 2008). In view 
of the sequence homology between the family members and 
the aforementioned findings, we postulated that all four family 
members associate with caveolae. Consistent with this hypothe-
sis, all four cavins showed colocalization with Cav1 at the cell 
surface when expressed in BHK cells (Fig. 3 a). As observed 
previously with PTRF/Cavin-1 (Hill et al., 2008), Cavin-2, -3, 
and -4 did not associate with caveolin in the Golgi, which may 
indicate that these proteins recognize the plasma membrane 
Liu et al., 2008). The levels of Cavin-2 and -3 proteins were also 
reduced in the tissues where Cavin-1 and other cavins are co-
expressed, although this loss was not to the same extent as the 
reduction in caveolins. Cavin-3 and Cavin-4 proteins were gen-
erally the least affected by the absence of Cavin-1 (Fig. 2 a), and 
Cavin-3 is expressed in liver and brain where the other caveolae 
proteins are expressed at very low levels. Interestingly, Cavin-4 
expression levels in cardiac and skeletal muscle were not affected 
by the absence of Cavin-1 (Fig. 2 a). Cavin-3, which is most highly 
expressed in cardiac muscle, was also not affected by the loss of 
Cavin-1 in this tissue (Fig. 2 a). Strengthening the link to caveo-
lae, levels of Cavin-2 and -3 were also decreased in tissues from 
mice lacking Cav1, whereas Cavin-4 levels were decreased in 
cardiac muscle but not in skeletal muscle (unpublished data), 
where the isoform Cav3 is predominant over Cav1 (Way and 
Parton, 1995; Parton et al., 1997). Collectively, the results in 
Cavin-1/ and Cav1/ tissues suggest that these proteins are to 
some extent coregulated at the level of protein expression/stability. 
In addition, the results in Cavin-1/ tissues suggest that the cavin 
proteins may have independent cellular functions.
To further examine the interdependence of the cavin family 
members, we also determined the expression of cavins in 3T3-L1 
adipocytes that have abundant caveolae (Fig. 2 b). Interestingly, 
in contrast to results from Cavin-1/ tissues, our knockdown 
Figure 2. Cavin family members are down-
regulated in cavin-1 knockout mice. (a) Tissue 
lysates from WT (+/+) and cavin-1 knockout 
mice (/) from the indicated tissues were 
prepared in RIPA buffer. Heavy and light expo-
sures of Cavin-3 are shown to best demonstrate 
its distribution. Equal protein amounts were 
subjected to SDS-PAGE and immunoblotted 
with the indicated antibodies. Ad, adipose tis-
sue; Lu, lung; Li, liver; Br, brain; He, heart; Mu, 
skeletal muscle; St, stomach; SB, small bowel; 
Ki, kidney; Sp, spleen; Te, testis. (b) Cavin-1 
to -3, Cav1, and Cav2 are down-regulated 
in shRNA (Sh) knockdown 3T3-L1 adipocytes. 
Whole cell lysates from Cavin-1–shRNA (Liu 
and Pilch, 2008) or Cavin-2–shRNA knock-
down adipocytes were analyzed by Western 
blotting with the indicated antibodies. C, control. 
Molecular masses (in parentheses) are given 
in kilodaltons.
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Figure 3. Cavins colocalize with caveolin and are dependent on caveolin for surface localization. (a) BHK cells transfected with GFP-tagged Cavin-1, -2, 
-3, or -4 (green) were PFA fixed and immunolabeled for endogenous Cav1 (red). Cavin family members and Cav1 extensively colocalized in a pattern 
consistent with caveolae distribution. Insets show enlargements of the selected areas. (b) WT and Cav1/ iMEFs were transfected with GFP-tagged cavins 
(green) and labeled for endogenous Cav1 (red). In WT iMEFs, cavins colocalized with Cav1 on the plasma membrane. In Cav1/ iMEFs, cavin proteins 
were mainly restricted to the cytosol, although in a small proportion of highly expressing cells, a surface pool of protein could be detected. Insets represent 
(from left to right) an enlargement of the selected area showing the merged image, GFP (green), and Cav1 (red). Bars, 10 µm.
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to proteolysis (also seen for Cavin-2; Fig. 2, a and b; and Fig. 4 e). 
It is notable that the only proteins stained in this gel aside 
from IgG are caveola components, and adipocyte caveolae-
 resident proteins such as CD36 (Souto et al., 2003) are absent. 
In confirmation of these data, we did reciprocal immunoprecipi-
tations of Cavin-1, -2, and -3, and we show in Fig. 4 e that each 
antibody is able to bring down the complex consisting of the 
other species.
All members of the cavin family  
interact in a multimeric complex in the  
cytosol of fibroblasts
To further demonstrate the interaction of the cavins with caveo-
lin, we chose fluorescence lifetime imaging microscopy (FLIM)/
fluorescence resonance energy transfer (FRET). Using a cavin-
EGFP construct as donor and Cav3–monomeric RFP as an 
acceptor, we observed a significant reduction in the EGFP fluores-
cence lifetime upon expression of all the cavin family mem-
bers (Fig. 5 a), indicating that these proteins are within close 
proximity to caveolin. To evaluate the possibility that cavin fam-
ily members form a multimeric complex, we used GFP-tagged 
SDR/Cavin-2, SRBC/Cavin-3, or MURC/Cavin-4 constructs as 
donors and PTRF/Cavin-1–Cherry as the acceptor. As shown 
by the very strong reduction in the donor lifetimes in Fig. 5 b, 
cavins are in close proximity to each other. Interestingly, as 
shown in Fig. 5 c, a similar interaction between the cavin pro-
teins was observed in Cav1/ iMEFs, suggesting that the cavin 
complex can be formed in the cytosol and is recruited to the 
forming caveolae.
We also examined the possible cytosolic interactions 
between cavins biochemically. Cavin-1–binding proteins 
were isolated from cytosol and membrane fractions prepared 
from WT iMEFs using an affinity-purified rabbit anti–Cavin-1 
antibody. Analysis of bound proteins by immunoblotting 
showed an interaction between Cavin-1, -2, -3, and -4 in both 
the cytosol and membrane fractions, whereas interaction 
with caveolin was only observed in the membrane fraction 
(Fig. 5 d). Note that although Cavin-4 was present at very 
low levels in iMEFs, a significant coimmunoprecipitation 
could still be detected. Thus, both FLIM/FRET and coimmuno-
precipitation experiments are consistent with the constitu-
tive formation of a cavin complex in the cytosol, which is 
recruited to plasma membrane caveolae. To further confirm 
that these proteins interact in a multiprotein complex, we 
performed immunoblotting after native gel electrophoresis. 
A single band of around 230 kD was detected by the Cavin-1 
and -4 antibodies in the cytosol of iMEFs (Fig. S1 a), which 
is consistent with a multiprotein complex formed between 
the cavin family members. This band was not observed in the 
membrane fraction, presumably because binding with caveo-
lin multimers produces a complex that is too large to enter 
the gel. However, based on our tissue expression data, the 
exact components of the complex in specific cell types may 
well be determined by the tissue-specific expression of the 
family members, and we cannot at present rule out the exis-
tence of multiple cavin complexes containing two or more 
family members.
environment generated by caveolin. Although plasma membrane 
Cav1 is organized in higher order oligomers, Golgi Cav1 is pre-
dominantly monomeric (Pol et al., 2005). Differences in oligo-
merization state may alter the lipid environment, leading to 
differential cavin recruitment. We next tested whether caveolin 
is necessary for recruitment of cavins to the plasma membrane 
using wild-type (WT) and Cav1/ immortalized mouse embry-
onic fibroblasts (iMEFs). All four cavins showed plasma mem-
brane association and colocalized with Cav1 in WT iMEFs, but in 
Cav1/ iMEFs, the cavin proteins accumulated in the cytosol 
(Fig. 3 b).
PTRF/Cavin-1, SDR/Cavin-2, and  
SRBC/Cavin-3 form a caveolar complex  
in adipocytes
Adipocytes are a rich source of caveolae, and we have devised 
protocols for their rapid purification from this tissue (Souto 
et al., 2003), allowing us to identify by proteomic analysis PTRF/
Cavin-1, SDR/Cavin-2, and SRBC/Cavin-3 (Fig. 4 d; Pilch 
et al., 2007). Cultured murine adipocytes such as 3T3-L1 cells 
acquire their fatty phenotype during differentiation (Green 
and Kehinde, 1976), which occurs at about the same time as a 
dramatic increase in Cav1 protein expression and caveola for-
mation (Scherer et al., 1994; Kandror et al., 1995). Thus, we 
examined the expression of the Cavin-1 to -3 during the pro-
cess of adipocyte differentiation. As shown in Fig. 4 a, Cavin-3 
levels are relatively high even in the nondifferentiated cells 
(days 0 and 2) and do not significantly change from day 2 to 
day 8. Cavin-1 and Cav1 appear coincidentally on day 2 fol-
lowed by Cavin-2 on day 6. Glut4 appears on day 4, which 
serves as a control for the differentiation process and acquisi-
tion of insulin-sensitive glucose transport (Birnbaum, 1989). 
Therefore, the adipocyte differentiation model is not only use-
ful for its classical role in determining the ontogeny of adipocyte-
specific processes, but it also allows us to determine a possible 
assembly hierarchy for the proteins associated with and 
involved in caveola biogenesis. In agreement with these 
results, the immunogold electron microscopic (immuno-EM) 
analysis of adipocyte plasma membrane “sheets” (Vinten et al., 
2001, 2005; Souto et al., 2003; Voldstedlund et al., 2003) 
documents the presence of Cavin-2 (Fig. 4 b) and Cavin-3 
(Fig. 4 c) exclusively in or very near to caveola structures. 
Previous analysis by immuno-EM revealed Cav1 (Voldstedlund 
et al., 2003) and Cavin-1 (Vinten et al., 2001, 2005) to deco-
rate these same structures in similar abundance, which is in 
accordance with a 1:1 ratio we have observed in fibroblasts 
(Hill et al., 2008). However, it is clear that Cavin-1 (Vinten 
et al., 2001, 2005) and Cavin-2 (Fig. 4 b) are present in mul-
tiple copies in all caveolae.
To determine how these proteins might interact at the 
plasma membrane of adipocytes, we performed immuno-
precipitation from plasma membrane fractions with anti–Cavin-1 
antibody followed by silver staining and mass spectrometry 
analysis of the stained bands. As shown in Fig. 4 d, all three 
proteins plus Cav1 and -2 were identified in this way. We often 
observe multiple Cavin-1 bands by immunoblotting (not de-
picted) as we see in Fig. 4 d, apparently a result of its susceptibility 
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PTRF/Cavin-1 is required for recruitment 
of the cavin complex to caveolae
We have previously shown that prostate cancer PC3 cells express 
Cav1, but not PTRF/Cavin-1, and that expression of Cavin-1 
alone is sufficient to generate caveolae (Hill et al., 2008). None 
of the four cavin proteins were detectable in PC3 cells (not 
depicted), and cavin transcripts were present at extremely low 
levels in PC3 cells in comparison with the mRNA for Cav1 
(Fig. 6 a). We used this system to determine whether other cavins 
showed the same ability as Cavin-1 to induce caveola formation. 
Figure 4. Cavin-1 to -3 forms a complex at caveolae in adipocytes. (a) Cavin-1 to -3 and Cav1 are induced during 3T3-L1 adipocyte differentiation (note 
that Cavin-4 is not normally expressed in adipocytes). Total cell lysates were prepared from 3T3-L1 cells on the indicated day after induction of differentia-
tion. Equal amounts of protein were analyzed by immunoblotting. Fodrin is shown as loading control. (b and c) Electron micrographs show a view of the 
cytoplasmic face of the adipocyte plasma membrane immunogold labeled for Cavin-2 (b) and Cavin-3 (c). The presence of Cavin-2 and -3 are primarily 
exclusively in or very near to clustered or single caveolar structures in multiple copies. Bars, 100 nm. (d) Cavin-1 to -3 forms a complex. 100 µg plasma 
membrane from primary adipocytes was solubilized in lysis buffer and immunoprecipitated with 3 µg anti–Cavin-1 or nonspecific IgG. The bound proteins 
were subjected to SDS-PAGE, silver stained as shown, and bands were identified as the indicated proteins (arrows) by mass spectrometry. (e) Similar 
immunoprecipitations were performed using anti–Cavin-1, -2, or -3 antibodies or nonspecific IgG. After SDS-PAGE, the bound proteins were analyzed 
by immunoblotting. IP, immunoprecipitation. Molecular masses (in parentheses) and markers are indicated in kilodaltons.
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PC3 cells stably expressing GFP-tagged cavins were generated 
and FACS sorted to obtain 95% pure populations of expressing 
cells. Western blotting showed that all four members were ex-
pressed as full-length fusion proteins with no significant deg-
radation (Fig. S1 b). Examination of endogenous Cav1 by 
immunofluorescence suggested that only Cavin-1 caused a re-
distribution of Cav1 from a diffuse pattern over the cell surface 
to a punctate pattern (Fig. 6 b). In addition, Cavin-1, but not the 
other family members, colocalized with Cav1 at the plasma 
membrane and associated with the plasma membrane in a punc-
tate pattern (note that the MeOH fixation used in Fig. 6 b clearly 
shows the redistribution of Cav1, but it does not preserve the co-
localization between Cavin-1 and Cav1; Fig. S1 c). Consistent 
with this observation, EM analysis showed that only Cavin-1 
induced abundant caveolae formation in >80% of the analyzed 
cells, whereas all the other family members showed several 
caveolae that were similar to that observed for GFP alone (Fig. 6, 
d–f). Note that in a very small proportion of SDR/Cavin-2– 
expressing cells, a very low number of morphological caveolae 
at the plasma membrane was observed, raising the possibility 
that Cavin-2 has some propensity to stabilize/generate caveolae, 
but this was orders of magnitude lower than for Cavin-1.
Figure 5. Cavin proteins form a multimeric 
complex and interact with caveolin. (a and b) 
BHK cells transiently expressing GFP-tagged 
cavin family members with or without Cav3-
RFP (a) or expressing different combinations 
of fluorescently tagged cavin proteins (b) were 
analyzed using FLIM/FRET as detailed previ-
ously in Hill et al. (2008). In c, WT or Cav1/ 
iMEFs expressing tagged cavin family members 
were analyzed by FLIM/FRET. Data represent 
mean GFP fluorescence lifetime ± SEM. All of 
the family members presented a significant re-
duction in GFP lifetime when coexpressed with 
Cav3-RFP (a) and Cavin-1–Cherry (b and c), 
indicating that these proteins are in close prox-
imity. P-values of Student’s t test are indicated; 
n = 80–150 cells. (d) Cavin-1–binding pro-
teins were isolated from equivalent volumes of 
cytosol (C) and membrane (M) fractions pre-
pared from WT iMEFs using Cavin-1 antibody 
or normal rabbit IgG as control. Binding to 
Cavin-2, -3, and -4 was observed in both cyto-
sol and membrane fractions, whereas caveolin 
binding was only detected in the membrane 
fraction. Longer exposure of starting material 
detected cavin bands of corresponding sizes 
(not depicted). Result is representative of three 
independent experiments. Molecular masses 
(in parentheses) are indicated in kilodaltons.
Interestingly, when PTRF/Cavin-1 and MURC/Cavin-4 
were coexpressed in PC3 cells, Cavin-4 was recruited to the 
plasma membrane where it colocalized with Cavin-1 and Cav1 
(Fig. 6 c). These results suggest that Cavin-1 is required to re-
cruit the cavin complex to caveolae where the other members 
may mediate distinct functions.
MURC/Cavin-4 localizes to sarcolemmal 
caveolae in muscle, and its distribution is 
perturbed in muscle disease
In contrast to our data showing association of cavins with cave-
olae, MURC/Cavin-4 was recently reported to be a cytosolic 
protein in muscle (Ogata et al., 2008; Tagawa et al., 2008). To 
further investigate the localization and function of Cavin-4 in 
muscle, we first determined the expression of Cavin-4 during 
C2C12 differentiation. As shown in Fig. 7 a, Cavin-4 expression 
is low in myoblasts but is increased upon differentiation, 
appearing after 6 h slightly before detection of Cav3 at 12 h 
(Fig. 7 a). Note that a very low level of Cavin-4 could be de-
tected in myoblasts upon longer exposure times (not depicted) 
in concordance with the low expression level we detect in fibro-
blasts (Fig. 5). PTRF/Cavin-1 is expressed in myoblasts and 
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Figure 6. Cavin-1, but not other cavins, generates caveolae in a heterologous system. (a) Relative expression of cavins and Cav1 mRNA in comparison 
with 18S RNA in PC3 cells was measured by RT-PCR. The y axis was divided to compare the cavins and Cav1 expression in the same scale. (b) PC3 cells 
stably expressing GFP-tagged cavins (green) were FACs sorted, methanol fixed, and immunolabeled for endogenous Cav1 (red). Only Cavin-1 caused 
Cav1 redistribution from a diffuse surface pattern to puncta consistent with caveolae formation (Hill et al., 2008). (c) PC3 cells transiently transfected with 
Cavin-4–GFP (green) alone or in combination with Cavin-1–Cherry (red) were methanol fixed and immunolabeled for endogenous Cav1 (blue). In cells 
expressing Cavin-4 plus Cavin-1, Cavin-4 colocalizes with Cav1 and Cavin-1 at the plasma membrane. Insets show a magnified view of the selected areas. 
(d) Quantitation of caveolae in stably transfected PC3 cell lines by EM expressed as mean ± SEM per cell. Caveolae were defined morphologically as 
plasma membrane (i.e., ruthenium red positive) pits/vesicular profiles of a diameter <100 nm. The number of such structures over the entire surface of at 
least 10 cell profiles per condition was determined and expressed as mean ± SEM per cell. Similar results were obtained in two independent experiments. 
(e and f) Representative micrograph of caveolae in PC3 cells stably expressing Cavin-1. Bars: (b) 10 µm; (e) 500 nm; (f) 200 nm.
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organized radial arrays of Cavin-4 labeling over the sarcolemma 
of the muscle (Fig. 7 c), which partially colocalized with Cav3 
(not depicted). We next examined the distribution of Cavin-4 at 
the ultrastructural level in C2C12 myotubes and in skeletal 
muscle by immuno-EM on frozen sections. Specific labeling 
myotubes (Fig. 7 a), which is consistent with its broader tissue 
distribution (Fig. 2). In C2C12 myotubes and adult mouse skel-
etal muscle tissue, Cavin-4 colocalizes with Cav3 at the light 
microscopic level (Fig. 7 b). In isolated muscle fibers, high res-
olution light microscopic analysis of Cavin-4 showed highly 
Figure 7. Immunogold electron micro-
scopic localization of endogenous Cavin-4 in 
C2C12 cells. (a) Expression of Cavin-1, -4, and 
Cav3 during C2C12 myotubes differentiation. 
Protein expression was analyzed by Western 
blotting at selected intervals after the initiation 
of differentiation. On longer exposures, low lev-
els of Cavin-4 were also detected in myoblasts. 
Note that although in cardiac and skeletal mus-
cle preparations Cavin-4 consistently migrates 
at 43 kD, in C2C12 myotubes, a major band 
is detected around 50 kD, possibly indicating 
a posttranslational modification in this cell 
type. (b) Myotubes (4 d) were methanol fixed, 
labeled for endogenous Cavin-4 (green) and 
Cav3 (red), and the top surface of the myotube 
was imaged using a confocal microscope. 
Insets show a magnified view of the selected 
areas. (c) Isolated muscle fibers were immuno-
labeled with anti–Cavin-4 antibody and 
analyzed by high resolution light microscopic 
analysis. Cavin-4 labeling was observed over 
the sarcolemma of the muscle with very low 
intracellular labeling. (d–f) C2C12 myotubes 
were immunolabeled for Cavin-4 using affinity-
purified antibodies followed by 10 nm protein 
A gold. Specific labeling is associated with 
pits and vesicular profiles close to the plasma 
membrane (PM) with the typical morphology of 
caveolae. Arrows indicate gold particles label-
ing Cavin-4 at the plasma membrane. (g and h) 
Immuno-EM localization of Cavin-1 (g) and 
-4 (h) in cardiac muscle. A gallery of images 
showing regions of cardiac tissue containing 
both endothelial cells (Ec) and cardiac muscle 
(Cm). Cavin-1 is associated with caveolae of 
both endothelial cells and cardiac muscle (left, 
arrows). Note the high density of labeling as-
sociated with the cytoplasmic face of the cave-
olae (right, arrows). Cavin-4 is not detectable 
on endothelial caveolae but associates with 
vesicular profiles with caveolar morphology 
in cardiac muscle (arrows). Molecular masses 
(in parentheses) are indicated in kilodaltons. 
Bars: (b and c) 20 µm; (d–h) 100 nm.
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Changes in Cav3 are associated with muscle diseases 
termed caveolinopathies (for review see Woodman et al., 2004). 
We therefore investigated whether Cavin-4 is mislocalized in 
the muscle of these patients. In transverse sections of skeletal 
muscle from normal mouse and human samples, Cavin-4 local-
izes to the sarcolemmal membrane (Fig. 8 a). A patient with 
rippling muscle disease, who shows a mosaic pattern of Cav3 
staining (unpublished data), shows a striking absence of Cavin-4 
from the Cav3-negative fibers (Fig. 8 b). Cavin-1 showed a sim-
ilar absence from Cav3-negative fibers (unpublished data). By 
Western blotting (Fig. 8 c), we observed a mild reduction (23%) 
in the levels of Cavin-4. We conclude that Cavin-4 is a new can-
didate protein for caveolin-associated muscle disease.
Discussion
In this study, we provide the first description of a multimeric 
protein complex that associates with caveolae and regulates 
caveola formation. The cavin complex can be present in the 
cytosol, but it is recruited by caveolin to generate caveolae. 
PTRF/Cavin-1 is a crucial component for recruitment of this 
was observed in pits and vesicular profiles close to the plasma 
membrane of the C2C12 myotubes (Fig. 7, d–f) and skeletal 
muscle (not depicted) consistent with the association of Cavin-4 
with caveolae. Myoblasts in the culture showed negligible label-
ing (unpublished data). Furthermore, labeling of PFA-fixed car-
diac tissue showed labeling for Cavin-1 in both endothelial cells 
and cardiac muscle, whereas Cavin-4 was only detectable in the 
cardiac muscle (Fig. 7, g and h). In each case, labeling was ob-
served in association with structures with the morphology of 
caveolae, i.e., 65-nm diameter pits or vesicular profiles generally 
close to the sarcolemma or endothelial cell plasma membrane. 
Although labeling per caveola was variable in thin sections, a 
labeling density of up to five golds per caveola profile for both 
Cavin-1 (Fig. 7 g) and Cavin-4 (Fig. 7 h) is consistent with a high 
number of cavin molecules per caveola in the same range as 
Cav1. This is consistent with labeling of Cavin-2 and -3 in plasma 
membrane lawns (Fig. 4) and with previous estimates of the stoi-
chiometry of Cavin-1 and Cav1 (Hill et al., 2008). Collectively, 
these results show that Cavin-4 is a caveolar protein in skeletal 
and cardiac muscle, and together with the other members of the 
cavin family, it likely forms a structural complex at caveolae.
Figure 8. Cavin-4 localization is perturbed in mus-
cle disease. (a) Cryosections from mouse and human 
skeletal muscle were immunolabeled for Cavin-4, 
showing localization to sarcolemmal membrane. 
(b) Immunolabeling of Cav3 in a patient with rippling 
muscle disease (Cav3 mosaic) reveals markedly re-
duced Cav3 and Cavin-4 staining in a subpopulation 
of muscle fibers (indicated by asterisks). (c) Cavin-4 
expression was reduced in muscle from Cav3 mosaic 
samples in comparison with control tissue. 10 µg 
muscle lysate was loaded. -Dystroglycan expression 
and coomassie staining of actin demonstrate relative 
loading of muscle protein. Molecular masses (in paren-
theses) are indicated in kilodaltons. Bars, 50 µm.
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The association with surface caveolae is disrupted by cholesterol 
depletion, which perturbs caveolar structure (Hill et al., 2008). 
Collectively with the results of this study, these results suggest 
that the cavin complex can act to sense changes in caveolar 
structure or composition. The release of the cavin complex on 
caveolar disruption could then provide a signaling mechanism 
from the cell surface to intracellular compartments, a fascinat-
ing possibility in view of the strengthening links between cave-
olae and mechanosensation as well as potential nuclear functions 
(Ogata et al., 2008; Tagawa et al., 2008).
All four cavin proteins can be detected in skeletal muscle 
preparations (Fig. 2 a), but SRBC/Cavin-3 and MURC/Cavin-4 
are highly expressed, suggesting a particularly important role 
in this tissue. MURC/Cavin-4 is evolutionarily conserved, and 
high throughput analysis of expression of proteins in the devel-
oping zebrafish embryo also suggests that a putative zebrafish 
orthologue is expressed predominantly in skeletal muscle 
(Thisse and Thisse, 2004). Recent studies provided the first in-
sights into the function of MURC/Cavin-4 (Ogata et al., 2008; 
Tagawa et al., 2008). MURC/Cavin-4 was shown to activate the 
extracellular signal-regulated kinase pathway, influencing skel-
etal muscle differentiation, and to activate RhoA and regulate 
the Rho–ROCK pathway, modulating cardiac function. Over-
expression of MURC/Cavin-4 in skeletal muscle and cardiac mus-
cle promoted myogenesis and caused cardiac dysfunction and 
conduction disturbance, respectively. Consistent with this study, 
MURC/Cavin-4 was shown to interact with SDR/Cavin-2 (Ogata 
et al., 2008). MURC/Cavin-4 was suggested to be a purely 
cytosolic protein in muscle, but our results, using multiple in-
dependent techniques, including immunogold EM of the endog-
enous protein, show the caveolar localization of the protein. 
MURC/Cavin-4 is enriched in cardiac and skeletal muscle but is 
clearly present at low levels in other cell types, such as embry-
onic fibroblasts, as shown in this study. We have also shown that 
MURC/Cavin-4 is a new candidate protein for caveolin-related 
muscle disease. Muscle from a patient with mosaic expression 
of Cav3 shows a striking loss of sarcolemmal MURC/Cavin-4 in 
the Cav3-negative fibers. As a possible sensor of caveolar form, 
study of the cavin complex in muscle diseases of unknown etiol-
ogy may provide insights into caveolinopathies where mutations 
in Cav3 are not the primary defect. In addition, these experi-
ments raise the possibility, which is being tested at present, that 
mutations in MURC/Cavin-4 directly cause muscle disease.
The identification of a possible caveola coat complex, as 
shown in this study, will provide new insights into the genera-
tion and function of this newly discovered molecular assembly. 
Whether the cavin complex shows any similarity in basic 
design principles and in the mechanisms of assembly and dis-
assembly to other well-characterized coat complexes is now 
amenable to analysis.
Materials and methods
Antibodies and reagents
Monoclonal antibodies recognizing Cavin-1 (Vinten et al., 2001), Cav1 
(Souto et al., 2003), and Glut4 (James et al., 1988) have been previously 
described. Antibodies against Cav1-3 and Cavin-1 were obtained from 
BD. Antibodies against Cavin-1 to -4 were raised in rabbits using keyhole 
complex to caveolae, establishing a hierarchy of interactions 
required for caveola formation. Indeed, in cultured adipocytes, 
PTRF/Cavin-1 and Cav1 show identical temporal expression 
followed by that of SDR/Cavin-2, suggesting that the latter is 
recruited to caveolae after their formation at the cell surface. 
In addition, we have characterized a new member of the family, 
MURC/Cavin-4, and demonstrated both the caveolar localiza-
tion of this protein and its redistribution in caveolin-associated 
muscle disease. The role of PTRF/Cavin-1 in caveola stability 
and/or formation and the density of the cavin proteins on the 
cytoplasmic face of caveolae, as shown by immuno-EM (Fig. 4 
and Fig. 7), raises the possibility that the cavin complex acts as 
a coatlike structural component of caveolae.
This study has shown that cavins are dependent on caveo-
lins for membrane association. Cavin family members show 
tissue-specific expression, pointing to regulation of the cavin 
complex at a transcriptional level, which in turn regulates cave-
ola function. Strengthening the association and cofunction 
of the cavin proteins, we show that SDR/Cavin-2 and SRBC/
Cavin-3 proteins are down-regulated in cavin-1 knockout mice 
and cell lines. Furthermore, in view of the differences in the ex-
pression of these proteins in different tissues, it is likely that the 
members of this family have functions outside the caveolar 
structure. Although cavins are dependent on caveolins for mem-
brane association, we were able to detect similar levels of inter-
action between PTRF/Cavin-1 and the other cavin family 
members in the WT and Cav1/ fibroblasts by FLIM/FRET, 
suggesting that the complex formation is not dependent on 
caveolins. By PTRF/Cavin-1 coimmunoprecipitation, we showed 
that the complex contained all the four cavin proteins in the 
cytosol with the additional binding of caveolin in the membrane 
fraction. This suggests a model in which cavin proteins consti-
tutively associate in the cytosol and are recruited to membrane 
caveolae. Lipid binding is also likely to play a significant role 
in cavin association with caveolae through multiple PS-binding 
components with possible parallels to lipid (PIP2, in the AP2 
complex) binding of adaptor complex components. The inter-
action of AP2 components with these lipids is of low affinity, 
but this weak binding is enhanced by other interactions includ-
ing oligomerization to generate a complex with multiple lipid-
interacting sites (Carlton and Cullen, 2005) as well as interactions 
with cargo proteins (Honing et al., 2005). These mutually stabi-
lizing interactions cause the AP2 complex to act as a coinci-
dence detector, relying on the multiple interactions to generate 
a high avidity interaction (Carlton and Cullen, 2005). In concor-
dance with this hypothesis, MURC/Cavin-4 is also able to inter-
act with PS in vitro (unpublished data) as previously shown for 
PTRF/Cavin-1, SDR/Cavin-2, and SRBC/Cavin-3 (Burgener 
et al., 1990; Izumi et al., 1997; Gustincich et al., 1999; Hill et al., 
2008). Interestingly, caveolin peptides have been suggested to 
generate domains enriched in PS in a liposome-based system 
(Wanaski et al., 2003), a process that could further enhance the 
avidity of the cavin interaction with caveolin-rich domains. This 
model of coincidence detection also offers a mechanism to rap-
idly disassemble the caveolin–cavin complex upon modulation 
of one of the components, as suggested for phosphoinositide-
based membrane complex formation (Carlton and Cullen, 2005). 
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for 5 min. The supernatant was centrifuged at 100,000 g for 30 min to 
generate a cytosolic S100 fraction and a membrane P100 pellet. The frac-
tions were adjusted to 50 mM NaCl and 0.1% NP-40, with the P100 be-
ing first solubilized in buffer A containing 250 mM NaCl and 0.5% NP-40. 
Fractions were incubated with protein A dynabeads precoupled with 
Cavin-1 antibody and rotated for 90 min. Beads were washed three times, 
and proteins bound were eluted using SDS-PAGE sample buffer without 
DTT and analyzed by Western blotting (Hill et al., 2008).
Quantitative RT-PCR
RNA was extracted using RNAeasy (QIAGEN), and 4–5 µg was reversely 
transcribed. Quantitative RT-PCR was performed in triplicate on three inde-
pendent RNA preparations. cDNA levels were analyzed in PCR reactions 
with SYBR Green Technologies (Applied Biosystems), and the relative level 
of expression was normalized using 18S ribosomal RNA. Statistical analy-
sis was performed on the average of three independent assays using Stu-
dent’s t test. Primer sequences can be provided on request.
EM analysis
Immuno-EM on adipocyte plasma membrane sheets was performed as de-
scribed previously in Vinten et al. (2001). EM analysis of caveola forma-
tion and quantification in PC3 cells was performed as described previously 
in Hill et al. (2008). For localization of Cavin-4, C2C12 myotubes and 
mouse skeletal (quadriceps) or cardiac muscle was fixed with 4% PFA and 
processed for immuno-EM as described previously (Hill et al., 2008). Ultra-
thin sections were labeled using affinity-purified antibodies to Cavin-4 fol-
lowed by 10 nm protein A gold.
Online supplemental material
Fig. S1 shows native gel immunoblotting for Cavin-1 and -4, immunoblotting 
of GFP-tagged cavins stably expressed in PC3 cells, and colocalization of 
Cavin-1 and Cav1 in PC3 cells. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200903053/DC1.
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